<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-028X</journal-id>
<journal-title><![CDATA[Vaccimonitor]]></journal-title>
<abbrev-journal-title><![CDATA[Vaccimonitor]]></abbrev-journal-title>
<issn>1025-028X</issn>
<publisher>
<publisher-name><![CDATA[Finlay Ediciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-028X2003000400001</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estandarización de los métodos electroforéticos en geles de poliacrilamida en el Phast System y cromatográficos para la caracterización de nuevos antígenos vacunales y componentes de medios de cultivo]]></article-title>
<article-title xml:lang="en"><![CDATA[Phast System acrylamyde gel electrophoresis and chromatography method standardization for the characterization of new vaccine antigens and culture media components]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Ileana]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Padrón]]></surname>
<given-names><![CDATA[María de los Ángeles]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cabrera]]></surname>
<given-names><![CDATA[Rubén]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta]]></surname>
<given-names><![CDATA[Michel]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pino]]></surname>
<given-names><![CDATA[Yadira]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[Yamisley]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Miguel E]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bracho]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aranguren]]></surname>
<given-names><![CDATA[Yisabel]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández]]></surname>
<given-names><![CDATA[Yovania]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[José Luis]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[Marta]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Esnard]]></surname>
<given-names><![CDATA[Sara Catalina]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Finlay  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2003</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2003</year>
</pub-date>
<volume>12</volume>
<numero>4</numero>
<fpage>1</fpage>
<lpage>8</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-028X2003000400001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-028X2003000400001&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-028X2003000400001&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[En este trabajo se realizó un análisis de diferentes parámetros que caracterizan la estandarización para la determinación del tamaño molecular de nuevos antígenos de interés vacunal, a través de electroforesis en &#8220;Phast System&#8221; y de distintas matrices cromatográficas. La evaluación electroforética de la linealidad en las curvas de patrones indicó valores de coeficientes de correlación y determinación superiores a 0,98, con una adecuada repetibilidad; no se manifestaron diferencias entre los resultados obtenidos por varios analistas, en días diferentes y el método resultó ser exacto y robusto en las condiciones recomendadas. Se evaluaron los parámetros que caracterizan la eficiencia en el empaquetamiento de cuatro matrices cromatográficas (Superosa 12, Sephacryl S-100, Sepharosa CL- 4B y Sephacryl S-1000). Los resultados obtenidos para ambos sistemas de determinación permitieron la evaluación satisfactoria de muestras de proteínas de membrana externa y lipopolisacárido, procedentes de Vibrio cholerae, Leptospira ssp, Pseudomona aeruginosa y Shigella ssp.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[We have analyzed different parameters to standardize the molecular weight determination of new vaccine antigens by gel electrophoresis in the Phast System and by a chromatography method. Linearity was obtained by SDS-PAGE using the reference curves with correlation and determination coefficients higher than 0.98. Repeatability was acceptable and there were no differences between the results of several analysts obtained on three different days. This method is exact and robust under the recommended conditions. Column efficiency was evaluated in four chromatographic matrixes (Superosa 12, Sephacryl S-100 y Sepharosa CL- 4B y Sephacryl S-1000). Good results in both systems allowed the evaluation of outer membrane proteins and lipopolysaccharide from Vibrio cholerae, Leptospira ssp., Pseudomona aeruginosa, Shigella ssp.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Estandarización]]></kwd>
<kwd lng="es"><![CDATA[electroforesis]]></kwd>
<kwd lng="es"><![CDATA[cromatografía]]></kwd>
<kwd lng="es"><![CDATA[Vibrio cholerae]]></kwd>
<kwd lng="es"><![CDATA[Leptospira ssp]]></kwd>
<kwd lng="es"><![CDATA[Pseudomona aeruginosa]]></kwd>
<kwd lng="es"><![CDATA[Shigella ssp]]></kwd>
<kwd lng="en"><![CDATA[Standardization]]></kwd>
<kwd lng="en"><![CDATA[gel electrophoresis]]></kwd>
<kwd lng="en"><![CDATA[chromatography]]></kwd>
<kwd lng="en"><![CDATA[Vibrio cholerae]]></kwd>
<kwd lng="en"><![CDATA[Leptospira ssp]]></kwd>
<kwd lng="en"><![CDATA[Pseudomona aeruginosa]]></kwd>
<kwd lng="en"><![CDATA[Shigella ssp.]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana"><strong>ARTICULOS ORIGINALES</strong></font></p>     <p align="right">&nbsp;</p>     <p align="right"><strong><font size="4" face="Verdana">Estandarizaci&oacute;n de los m&eacute;todos electrofor&eacute;ticos en geles   de poliacrilamida en el Phast System y cromatogr&aacute;ficos   para la caracterizaci&oacute;n de nuevos ant&iacute;genos vacunales y  componentes de medios de cultivo.</font></strong></p>     <p align="right"><strong><font size="2" face="Verdana"><br />    </font></strong></p>     <p align="right"><strong><font size="2" face="Verdana"><font size="3">Phast System acrylamyde gel electrophoresis and chromatography method   standardization for the characterization of new vaccine antigens and culture media   components</font></font></strong>.</p>     <p align="justify">&nbsp;</p>     <p align="justify"><strong><font size="2" face="Verdana">Ileana Mart&iacute;nez, Mar&iacute;a de los &Aacute;ngeles Padr&oacute;n, Rub&eacute;n Cabrera, Michel Acosta, Yadira Pino, Yamisley   Gonz&aacute;lez, Miguel E. Mart&iacute;nez, Gustavo Bracho, Yisabel Aranguren, Yovania Fern&aacute;ndez, Jos&eacute; Luis P&eacute;rez,  Marta Gonz&aacute;lez, Sara Catalina Esnard, B&aacute;rbara Cedr&eacute;, Luis Garc&iacute;a</font></strong><font size="2" face="Verdana">.<br />  </font></p>     <p align="justify"><font size="2" face="Verdana">Instituto Finlay. Centro de Investigaci&oacute;n-Producci&oacute;n de Vacunas y Sueros. Ciudad de La Habana. Cuba. E-mail: <a href="emailto:imartinez@finlay.edu.cu">imartinez@finlay.edu.cu</a></font></p> <hr />     <p align="justify"><font size="2" face="Verdana">RESUMEN<br />  </font></p>     <p align="justify"><font size="2" face="Verdana">En este trabajo se realiz&oacute; un an&aacute;lisis de diferentes par&aacute;metros que caracterizan la estandarizaci&oacute;n   para la determinaci&oacute;n del tama&ntilde;o molecular de nuevos ant&iacute;genos de inter&eacute;s vacunal, a trav&eacute;s de   electroforesis en &ldquo;Phast System&rdquo; y de distintas matrices cromatogr&aacute;ficas. La evaluaci&oacute;n   electrofor&eacute;tica de la linealidad en las curvas de patrones indic&oacute; valores de coeficientes de   correlaci&oacute;n y determinaci&oacute;n superiores a 0,98, con una adecuada repetibilidad; no se   manifestaron diferencias entre los resultados obtenidos por varios analistas, en d&iacute;as diferentes y   el m&eacute;todo result&oacute; ser exacto y robusto en las condiciones recomendadas. Se evaluaron los   par&aacute;metros que caracterizan la eficiencia en el empaquetamiento de cuatro matrices   cromatogr&aacute;ficas (Superosa 12, Sephacryl S-100, Sepharosa CL- 4B y Sephacryl S-1000). Los   resultados obtenidos para ambos sistemas de determinaci&oacute;n permitieron la evaluaci&oacute;n   satisfactoria de muestras de prote&iacute;nas de membrana externa y lipopolisac&aacute;rido, procedentes de   Vibrio cholerae, Leptospira ssp, Pseudomona aeruginosa y Shigella ssp.<br /> </font></p>     ]]></body>
<body><![CDATA[<p align="justify"><font size="2" face="Verdana"><strong>Palabras claves:</strong> Estandarizaci&oacute;n, electroforesis, cromatograf&iacute;a, Vibrio cholerae, Leptospira ssp,  Pseudomona aeruginosa, Shigella ssp.</font></p> <hr />     <p align="justify"><font size="2" face="Verdana"><strong>ABSTRACT</strong></font></p>     <p align="justify"><font size="2" face="Verdana"><br />  We have analyzed different parameters to standardize the molecular weight determination of new   vaccine antigens by gel electrophoresis in the Phast System and by a chromatography method. Linearity   was obtained by SDS-PAGE using the reference curves with correlation and determination coefficients higher than 0.98. Repeatability was acceptable and there were no differences between the results of several analysts obtained on three different days. This method is exact and robust under the   recommended conditions. Column efficiency was evaluated in four chromatographic matrixes (Superosa 12, Sephacryl S-100 y Sepharosa CL- 4B y Sephacryl S-1000). Good results in both systems allowed the evaluation of outer membrane proteins and lipopolysaccharide from Vibrio cholerae, Leptospira ssp.,  Pseudomona aeruginosa, Shigella ssp.<br /> </font></p>     <p align="justify"><font size="2" face="Verdana"><strong>Keywords:</strong>Standardization, gel electrophoresis, chromatography, Vibrio cholerae, Leptospira ssp,  Pseudomona aeruginosa, Shigella ssp.</font></p> <hr />     <p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Texto completo formato PDF </font></p>     <p align="justify" class="Estilo4 Estilo15"><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>REFERENCIAS</strong></font></p>     <!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Farmacopea de los Estados Unidos de Am&eacute;rica. Edici&oacute;n XXIII. Estados Unidos; 1995. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. OMS. Technical Report Series 823. Validation of analytical procedures used in the examination of pharmaceutical material; 1992. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Cat&aacute;logo Amersham Biosciences en Latinoam&eacute;rica; 2003. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Gel filtration. Amersham Biosciences. Suecia; 2002 </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Campa C, Sierra G et al. Inventors. Centro Nacional de Biopreparados, assignee. Vaccine against group B Neisseria meningitides, gammaglobulin and transfer factor. Ep O301 992 A2; 1988. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Westphal O, Jam K. Bacterial Lipopolysaccharides. In Whistter RL (ed). Methods in carbohydrate chemistry. Academic Press. Inc. New York; 1965. 5:83-91. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Pharmacia. Manual del Usuario Phast System. Suecia. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Casta&ntilde;eda P, Barn&eacute;s CG. M&eacute;todos anal&iacute;ticos. Validaci&oacute;n. Comisi&oacute;n Permanente de Farmacopea de Estados Unidos de M&eacute;xico. Secretar&iacute;a de Salud; 1991. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. U.S. Department of Health and Human Services. Food and Drug Administration (FDA). Analytical Procedures and Methods Validation. Guidance for Industry; 2000. </font><!-- ref --><p align="justify"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Protocolo de Validaci&oacute;n PV-11-028. Validaci&oacute;n del m&eacute;todo de electroforesis en geles de poliacrilamida para la determinaci&oacute;n de la identidad proteica de la vacuna VAMENGOCBC&#174;; 1999.</font>  ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Farmacopea de los Estados Unidos de América</collab>
<source><![CDATA[]]></source>
<year>1995</year>
<edition>XXIII</edition>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>OMS</collab>
<source><![CDATA[Technical Report Series 823: Validation of analytical procedures used in the examination of pharmaceutical material]]></source>
<year>1992</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Catálogo Amersham</collab>
<source><![CDATA[Biosciences en Latinoamérica]]></source>
<year>2003</year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<source><![CDATA[Gel filtration]]></source>
<year>2002</year>
<publisher-name><![CDATA[Amersham Biosciences]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Campa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Inventors]]></article-title>
<collab>Centro Nacional de Biopreparados</collab>
<source><![CDATA[Vaccine against group B Neisseria meningitides gammaglobulin and transfer factor: Ep O301 992 A2]]></source>
<year>1988</year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Westphal]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Jam]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Bacterial Lipopolysaccharides]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Whistter]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<source><![CDATA[Methods in carbohydrate]]></source>
<year>1965</year>
<page-range>83-91</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Pharmacia</collab>
<source><![CDATA[Manual del Usuario Phast System]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Barnés]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
</person-group>
<source><![CDATA[Métodos analíticos: Validación. Comisión Permanente de Farmacopea de Estados Unidos de México]]></source>
<year>1991</year>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>U.S. Department of Health and Human Services</collab>
<source><![CDATA[Food and Drug Administration (FDA): Analytical Procedures and Methods Validation. Guidance for Industry]]></source>
<year>2000</year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="">
<source><![CDATA[Protocolo de Validación PV-11-028: Validación del método de electroforesis en geles de poliacrilamida para la determinación de la identidad proteica de la vacuna VAMENGOCBC®]]></source>
<year>1999</year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
